We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
- Authors
Kroschinsky, Frank; Middeke, Jan Moritz; Janz, Martin; Lenz, Georg; Witzens-Harig, Mathias; Bouabdallah, Reda; La Rosée, Paul; Viardot, Andreas; Salles, Gilles; Kim, Seok Jin; Kim, Tae Min; Ottmann, Oliver; Chromik, Joerg; Quinson, Anne-Marie; von Wangenheim, Ute; Burkard, Ute; Berk, Andreas; Schmitz, Norbert
- Publication
Investigational New Drugs, 2021, Vol 39, Issue 1, p285
- ISSN
0167-6997
- Publication type
Correction Notice
- DOI
10.1007/s10637-020-00964-9